Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice

Journal of Cellular Biochemistry

Volumn 90, Issue 2, 2003, Pages 347-360

  Zeitlin, L ^a,b   Segev, E ^a   Fried, A ^a   Wientroub, S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

B lymphopoiesis; Bone marrow; Cytokines; Omega 3 fatty acids; Serum lipids; Skin adipocytes

Indexed keywords

ARZOXIFENE; CHOLESTEROL; FISH OIL; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DERMIS; DIET; ESTROGEN DEFICIENCY; FEMALE; LIPID BLOOD LEVEL; LYMPHOPOIESIS; NONHUMAN; OVARIECTOMY; PEROXISOME; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; ANTILIPEMIC AGENTS; BODY WEIGHT; BONE MARROW CELLS; CHOLESTEROL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; OVARIECTOMY; OVARY; PIPERIDINES; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SKIN; SPLEEN; THIOPHENES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141752760     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10620     Document Type: Article

References (63)

1. Alexander JW. 1998. Immunonutrition: The role of ω-3 fatty acids. Nutrition 14:627-633.
2. Ashby J, Odum J, Foster JR. 1997. Activity of raloxifene in immature and ovariectomized rat uterotrophic assays. Regul Toxicol Pharmacol 25:226-231.
3. Berger J, Moller DE. 2002. The mechanisms of action of PPARs. Annu Rev Med 53:409-435.
4. Blok WL, Deslypere J-P, Demacker PNM, van der Ven-Jongekrijg J, Hectors MPC, van der Meer JWM, Katan MB. 1997. Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for one year. Eur J Clin Invest 27:1003-1008.
5. Blum A, Cannon RO. 2001. Selective estrogen receptor modulator effects on serum lipoproteins and vascular function in postmenopausal women and in hypercholesterolemic men. Ann NY Acad Sci 949:168-174.
6. Boelsma E, Hendriks HFJ, Roza L. 2001. Nutritional skin care: Health effects of micronutrients and fatty acids. Am J Clin Nutr 73:853-864.
7. Brincat MP. 2000. Hormone replacement therapy and the skin. Maturitas 35:107-117.
8. Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, Chiarpotto E, Baeuerle PA, Poli G. 1996. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Comm 229:643-647.
9. Cerillo G, Rees A, Manchanda N, Reilly C, Brogan I, White A, Needham M. 1998. The oestrogen receptor regulated NFkB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol 67:79-88.
10. Cheleuitte D, Mizuno S, Glowacki J. 1998. In vitro secretion of cytokines by human bone marrow: Effects of age and estrogen status. J Clin Endocrinol Metab 83:2043-2051.
11. Clemett D, Spencer CM. 2000. Raloxifene: A review of its use in postmenopausal osteoporosis. Drugs 60:379-411.
12. Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. 2000. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: Evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor γ2. Endocrinology 141: 649-656.
13. Editorial. 1998. Cytokines, estrogen, and postmenopausal osteoporosis the second decade. Endocrinology 139:2659-2661.
14. Forman BM, Chen J, Evans RM. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and β. Proc Natl Acad Sci USA 94:4312-4317.
15. Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L, Jr. 2000. A pharmacological review of selective oestrogen receptor modulators. Hum Reprod Update 6:212-224.
16. Grimble RF. 1998. Nutritional modulation of cytokine biology. Nutrition 14:634-640.
17. Hogan HA, Ruhmann SP, Sampson HW. 2000. The mechanical properties of cancellous bone in the proximal tibia of ovariectomized rats. J Bone Miner Res 15:284-292.
18. James MJ, Gibson RA, Cleland LG. 2000. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71(Suppl):343S-348S.
19. Jiang C, Ting AT, Seed B. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
20. Jump DB. 2002. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 277:8755-8758.
21. Jump DB, Clarke SD. 1999. Regulation of gene expression by dietary fat. Annu Rev Nutr 19:63-90.
22. Kassem M, Khosla S, Spelsberg TC, Riggs BL. 1996. Cytokine production in the bone marrow microenvironment: Failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endocrinol Metab 81:513-518.
23. Kauffman RF, Bensch WR, Roudebush RE, Cole HW, Bean JS, Phillips DL, Monroe A, Cullinan GJ, Glasebrook AL, Bryant HU. 1997. Hypocholesterolemic activity of raloxifene (LY139481): Pharmacological characterization as a selective estrogen receptor modulator. Pharmacol Exp Ther 280:146-153.
24. Kaufman CK, Fuchs E. 2000. It's got you covered: NF-kB in the epidermis. J Cell Biol 149:999-1004.
25. Kline GH, Hayden TA, Klinman NR. 1999. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol 162: 3342-3349.
26. Klinge CM. 2001. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919.
27. Ma H, Sprecher HW, Kolattukudy PE. 1998a. Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARγ-expressing tissue. J Biol Chem 273:30131-30138.
28. Ma H, Tam QT, Kolattukudy PE. 1998b. Peroxisome proliferator-activated receptor γ1 (PPAR-γ1) as a major PPAR in a tissue in which estrogen induces peroxisome proliferation. FEBS Letters 434:394-400.
29. Medina KL, Strasser A, Kincade PW. 2000. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precurors. Blood 95:2059-2067.
30. Meunier PJ, Vignot E, Garnero P, Confavreux E, Paris E, Liu-Leage S, Sarkar S, Liu T, Wong M, Draper MW. 1999. Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Osteoporos Int 10:330-336.
31. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
32. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ. 2000. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71:1085-1094.
33. Muchmore DB. 2000. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist 5:388-392.
34. Nunez SB, Medin JA, Braissant O, Kemp L, Wahli W, Ozato K, Segars JH. 1997. Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor. Mol Cell Endocrinol 127:27-40.
35. Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T. 2000. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 15:541-549.
36. Padilla J, Kaur K, Harris SG, Phipps RP. 2000. PPAR-gamma-mediated regulation of normal and malignant B lineage cells. Ann NY Acad Sci 905:97-109.
37. Padilla J, Leung E, Phipps RP. 2002. Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin Immunol 103: 22-33.
38. Peng Z, Tuukkanen J, Zhang H, Vaananen HK. 1999. Alteration in the mechanical competence and structural properties in the femoral neck and vertebrae of ovariectomized rats. J Bone Miner Res 14:616-623.
39. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J. 1997. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 272:27307-27312.
40. Prestwood KM, Gunness M, Muchmore DB, Lu Y, Wong M, Raisz LG. 2000. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. J Clin Endocrinol Metab 85:2197-2202.
41. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82.
42. Roche HM, Gibney MJ. 2000. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 71:232S-237S.
43. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289:1508-1514.
44. Rogers A, Eastell R. 1998. Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. J Bone Miner Res 13:1577-1586.
45. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, Johnson KC, Morley Kotchen J, Ockene J. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321-333.
46. Rubin GL, Zhao Y, Kalus AM, Simpson ER. 2000. Peroxisome proliferator-activated receptor γ ligands inhibit estrogen biosynthesis in human breast adipose tissue: Possible implications for breast cancer therapy. Cancer Res 60:1604-1608.
47. Sadeghi S, Wallace FA, Calder C. 1999. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 96:404-410.
48. Saldeen T, Wallin R, Marklinder I. 1998. Effects of a small dose of stable fish oil substituted for margarine in bread on plasma phospholipid fatty acids and serum triglycerides. Nutr Res 18:1483-1492.
49. Sanchez R, Nguyen D, Rocha W, White JH, Mader S. 2002. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24:244-254.
50. Sato M, Turner CH, Wang T, Adrian MD, Rowley E, Bryant HU. 1998. LY353381.HCl: A novel raloxifene analog with improved SERM potency and efficacy in vivo. Pharmacol Exp Ther 287:1-7.
51. Sauerbronn AVD, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA. 2000. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 68:35-41.
52. Schlemmer CK, Coetzer H, Claassen N, Kruger MC. 1999. Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. Prostaglandins Leukot Essent Fatty Acids 61:381-390.
53. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J. 1996. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348.
54. Somers SD, Erickson KL. 1994. Alteration of tumor necrosis factor-α production by macrophages from mice fed diets high in eicosapentaenoic and docosahexaenoic fatty acids. Cell Immunol 153:287-297.
55. Stark KD, Park EJ, Maines VA, Holub BJ. 2000. Effects of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial. Am J Clin Nutr 72:389-394.
56. Thoennes SR, Tate PL, Price TM, Kilgore MW. 2000. Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells. Mol Cell Endocrinol 160:67-73.
57. Van Bezooijen RL, Farih-Sips HCM, Papapoulos SE, Lowik CWGM. 1998. IL-1α, IL-1β, IL-6, and TNF-α steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. J Bone Miner Res 13:185-194.
58. Vargas SJ, Naprta A, Lee S-K, Kalinowski J, Kawaguchi H, Pilbeam CC, Raisz LG, Lorenzo JA. 1996. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy. J Bone Miner Res 11:1926-1934.
59. Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawrence JB, Shah AS, Anderson PW. 1998. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 279:1445-1451.
60. 2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J Bone Miner Res 11:1321-1332.
61. Watkins BA, Li Y, Allen KGD, Hoffmann WE, Seifert MF. 2000. Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130:2274-2284.
62. Watkins BA, Li Y, Lippman HE, Seifert MF. 2001a. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med 226:485-497.
63. Watkins BA, Lippman HE, Le Bouteiller L, Li Y, Seifert MF. 2001b. Bioactive fatty acids: Role in bone biology and bone cell function. Prog Lipid Res 40:125-148.